NCT00820248 2023-08-22
Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer
Canadian Cancer Trials Group
Phase 3 Completed
Canadian Cancer Trials Group
Wake Forest University Health Sciences
Cancer Trials Ireland
National Cancer Institute (NCI)